These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 35394614)

  • 1. HIV-1 subtype C Tat exon-1 amino acid residue 24K is a signature for neurocognitive impairment.
    Ruhanya V; Jacobs GB; Paul RH; Joska JA; Seedat S; Nyandoro G; Glashoff RH; Engelbrecht S
    J Neurovirol; 2022 Jun; 28(3):392-403. PubMed ID: 35394614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic attributes of blood-derived subtype-C HIV-1 tat and env in India and neurocognitive function.
    Tilghman MW; Bhattacharya J; Deshpande S; Ghate M; Espitia S; Grant I; Marcotte TD; Smith D; Mehendale S
    J Med Virol; 2014 Jan; 86(1):88-96. PubMed ID: 24150902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV-1 Subtype C Vpr Amino Acid Residue 45Y and Specific Conserved Fragments Are Associated with Neurocognitive Impairment and Markers of Viral Load.
    Ruhanya V; Jacobs GB; Paul RH; Joska JA; Seedat S; Nyandoro G; Glashoff RH; Engelbrecht S
    AIDS Res Hum Retroviruses; 2023 Apr; 39(4):166-175. PubMed ID: 36401355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Evolving Profile of the Signature Amino Acid Residues in HIV-1 Subtype C Tat.
    Aralaguppe SP; Sharma S; Menon M; Prasad VR; Saravanan S; Murugavel KG; Solomon S; Ranga U
    AIDS Res Hum Retroviruses; 2016 May; 32(5):503-14. PubMed ID: 26678403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Signatures of HIV-1 subtype B and C Tat proteins and their effects in the neuropathogenesis of HIV-associated neurocognitive impairments.
    Williams ME; Zulu SS; Stein DJ; Joska JA; Naudé PJW
    Neurobiol Dis; 2020 Mar; 136():104701. PubMed ID: 31837421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. tat Exon 1 exhibits functional diversity during HIV-1 subtype C primary infection.
    Rossenkhan R; MacLeod IJ; Sebunya TK; Castro-Nallar E; McLane MF; Musonda R; Gashe BA; Novitsky V; Essex M
    J Virol; 2013 May; 87(10):5732-45. PubMed ID: 23487450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The evolution of subtype B HIV-1 tat in the Netherlands during 1985-2012.
    van der Kuyl AC; Vink M; Zorgdrager F; Bakker M; Wymant C; Hall M; Gall A; Blanquart F; Berkhout B; Fraser C; Cornelissen M;
    Virus Res; 2018 May; 250():51-64. PubMed ID: 29654800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic features of cerebrospinal fluid-derived subtype B HIV-1 tat.
    Choi JY; Hightower GK; Wong JK; Heaton R; Woods S; Grant I; Marcotte TD; Ellis RJ; Letendre SL; Collier AC; Marra CM; Clifford DB; Gelman BB; McArthur JC; Morgello S; Simpson DM; McCutchan JA; Richman DD; Smith DM;
    J Neurovirol; 2012 Apr; 18(2):81-90. PubMed ID: 22528397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clade C HIV-1 isolates circulating in Southern Africa exhibit a greater frequency of dicysteine motif-containing Tat variants than those in Southeast Asia and cause increased neurovirulence.
    Rao VR; Neogi U; Talboom JS; Padilla L; Rahman M; Fritz-French C; Gonzalez-Ramirez S; Verma A; Wood C; Ruprecht RM; Ranga U; Azim T; Joska J; Eugenin E; Shet A; Bimonte-Nelson H; Tyor WR; Prasad VR
    Retrovirology; 2013 Jun; 10():61. PubMed ID: 23758766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Codon optimization of the tat antigen of human immunodeficiency virus type 1 generates strong immune responses in mice following genetic immunization.
    Ramakrishna L; Anand KK; Mohankumar KM; Ranga U
    J Virol; 2004 Sep; 78(17):9174-89. PubMed ID: 15308713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular and Genetic Characterization of HIV-1 Tat Exon-1 Gene from Cameroon Shows Conserved Tat HLA-Binding Epitopes: Functional Implications.
    Teto G; Fonsah JY; Tagny CT; Mbanya D; Nchindap E; Kenmogne L; Fokam J; Njamnshi DM; Kouanfack C; Njamnshi AK; Kanmogne GD
    Viruses; 2016 Jul; 8(7):. PubMed ID: 27438849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular and genetic characterization of natural HIV-1 Tat Exon-1 variants from North India and their functional implications.
    Ronsard L; Lata S; Singh J; Ramachandran VG; Das S; Banerjea AC
    PLoS One; 2014; 9(1):e85452. PubMed ID: 24465566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV-1-Tat Protein Inhibits SC35-mediated Tau Exon 10 Inclusion through Up-regulation of DYRK1A Kinase.
    Kadri F; Pacifici M; Wilk A; Parker-Struckhoff A; Del Valle L; Hauser KF; Knapp PE; Parsons C; Jeansonne D; Lassak A; Peruzzi F
    J Biol Chem; 2015 Dec; 290(52):30931-46. PubMed ID: 26534959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of the HIV Tat C30C31S dicysteine substitution on neuropsychological function in patients with clade C disease.
    Paul RH; Joska JA; Woods C; Seedat S; Engelbrecht S; Hoare J; Heaps J; Valcour V; Ances B; Baker LM; Salminen LE; Stein DJ
    J Neurovirol; 2014 Dec; 20(6):627-35. PubMed ID: 25366660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intersubtype Genetic Variation of HIV-1 Tat Exon 1.
    Roy CN; Khandaker I; Oshitani H
    AIDS Res Hum Retroviruses; 2015 Jun; 31(6):641-8. PubMed ID: 25748226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigating the distribution of HIV-1 Tat lengths present in the Drexel Medicine CARES cohort.
    Link RW; Mele AR; Antell GC; Pirrone V; Zhong W; Kercher K; Passic S; Szep Z; Malone K; Jacobson JM; Dampier W; Wigdahl B; Nonnemacher MR
    Virus Res; 2019 Oct; 272():197727. PubMed ID: 31437485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional impact of HIV-1 Tat on cells of the CNS and its role in HAND.
    Marino J; Maubert ME; Mele AR; Spector C; Wigdahl B; Nonnemacher MR
    Cell Mol Life Sci; 2020 Dec; 77(24):5079-5099. PubMed ID: 32577796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV Tat causes synapse loss in a mouse model of HIV-associated neurocognitive disorder that is independent of the classical complement cascade component C1q.
    Hammond JW; Qiu WQ; Marker DF; Chamberlain JM; Greaves-Tunnell W; Bellizzi MJ; Lu SM; Gelbard HA
    Glia; 2018 Dec; 66(12):2563-2574. PubMed ID: 30325063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Viral diversity and diversification of major non-structural genes vif, vpr, vpu, tat exon 1 and rev exon 1 during primary HIV-1 subtype C infection.
    Rossenkhan R; Novitsky V; Sebunya TK; Musonda R; Gashe BA; Essex M
    PLoS One; 2012; 7(5):e35491. PubMed ID: 22590503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV-1 Tat second exon limits the extent of Tat-mediated modulation of interferon-stimulated genes in antigen presenting cells.
    Kukkonen S; Martinez-Viedma Mdel P; Kim N; Manrique M; Aldovini A
    Retrovirology; 2014 Apr; 11():30. PubMed ID: 24742347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.